Burcon NutraScience Corporation (TSX: BU)
Canada
· Delayed Price · Currency is CAD 0.205
+0.010 (5.13%)
Jul 19, 2024, 1:12 PM EDT
Burcon NutraScience Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Year Ending | TTM | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.18 | 0.18 | 0.36 | 0.17 | 0.26 | 0.03 | Upgrade
|
| Revenue Growth (YoY) | -49.34% | -49.34% | 112.23% | -33.70% | 730.75% | -22.51% | Upgrade
|
| Cost of Revenue | - | - | - | - | 0.79 | 0.85 | Upgrade
|
| Gross Profit | 0.18 | 0.18 | 0.36 | 0.17 | -0.53 | -0.82 | Upgrade
|
| Selling, General & Admin | 3.74 | 3.74 | 3.94 | 4.53 | 3.8 | 2.19 | Upgrade
|
| Research & Development | 3.46 | 3.46 | 3.95 | 3.38 | 0.53 | 0.72 | Upgrade
|
| Operating Expenses | 7.2 | 7.2 | 7.89 | 7.91 | 4.33 | 2.91 | Upgrade
|
| Operating Income | -7.02 | -7.02 | -7.53 | -7.74 | -4.86 | -3.72 | Upgrade
|
| Interest Expense | -0.41 | -0.41 | -0.2 | -0.06 | -0.7 | -0.59 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.41 | 0.41 | 0.45 | 0.23 | Upgrade
|
| Net Interest Expenses | -0.4 | -0.4 | 0.21 | 0.34 | -0.25 | -0.36 | Upgrade
|
| Income (Loss) On Equity Investments | - | - | -5.5 | -4.29 | -2.42 | -0.94 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | 0 | -0 | -0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.1 | -0.1 | -0.27 | 0.11 | 0.27 | 0.37 | Upgrade
|
| EBT Excluding Unusual Items | -7.52 | -7.52 | -13.08 | -11.59 | -7.26 | -4.65 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -7.99 | 0.96 | 6.38 | - | Upgrade
|
| Other Unusual Items | - | - | -4.36 | 0.34 | 0.26 | - | Upgrade
|
| Pretax Income | -7.52 | -7.52 | -25.42 | -10.29 | -0.62 | -4.65 | Upgrade
|
| Income Tax Expense | -0.08 | -0.08 | -0.06 | -0.03 | - | -0.02 | Upgrade
|
| Net Income | -7.45 | -7.45 | -25.36 | -10.26 | -0.62 | -4.63 | Upgrade
|
| Net Income to Common | -7.45 | -7.45 | -25.36 | -10.26 | -0.62 | -4.63 | Upgrade
|
| Shares Outstanding (Basic) | 121 | 121 | 109 | 109 | 103 | 79 | Upgrade
|
| Shares Outstanding (Diluted) | 121 | 121 | 109 | 109 | 103 | 79 | Upgrade
|
| Shares Change (YoY) | 11.65% | 11.65% | 0.13% | 5.54% | 30.35% | 79.64% | Upgrade
|
| EPS (Basic) | -0.06 | -0.06 | -0.23 | -0.09 | -0.01 | -0.06 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.06 | -0.23 | -0.09 | -0.01 | -0.06 | Upgrade
|
| Free Cash Flow | -5.9 | -5.9 | -6.38 | -5.97 | -3.93 | -3.47 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.05 | -0.06 | -0.05 | -0.04 | -0.04 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | -203.87% | - | Upgrade
|
| Operating Margin | -3807.23% | -3807.23% | -2067.88% | -4512.57% | -1877.56% | -11958.40% | Upgrade
|
| Profit Margin | - | - | - | - | -238.74% | - | Upgrade
|
| Free Cash Flow Margin | -3202.50% | -3202.50% | -1751.91% | -3478.73% | -1518.48% | -11158.77% | Upgrade
|
| EBITDA | -6.74 | -6.74 | -7.29 | -7.58 | -4.73 | -3.69 | Upgrade
|
| D&A For EBITDA | 0.28 | 0.28 | 0.24 | 0.16 | 0.12 | 0.04 | Upgrade
|
| EBIT | -7.02 | -7.02 | -7.53 | -7.74 | -4.86 | -3.72 | Upgrade
|
| Revenue as Reported | - | - | - | - | 0.26 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template.